ProCE Banner Series

PCE Oncology Bootcamp For Breast & GI Cancers 

Created specifically for the clinical needs of oncology NPs, PAs, and nurses, national experts will give their clinical perspectives on the management of gastrointestinal and breast cancers and prepare you for the future of care in these evolving fields. Live streamed for your convenience – all from the comfort of your home or office.

  AAPA
  | ANCC
Credits Available

4.50
ANCC | AAPA

Who Should Attend

NPs, PAs, and nurses who specialize in oncology

Faculty

ProCE Banner Faculty
Jeremy M. Force, DO

Assistant Professor
Department of Medicine
Division of Medical Oncology
Breast Oncology Program
Duke University
Durham, North Carolina

ProCE Banner Faculty
Robert Lentz, MD

Assistant Professor of Medicine
Department of Medicine
Division of Medical Oncology
University of Colorado School of Medicine and Cancer Center
Aurora, Colorado

ProCE Banner Faculty
Kathleen Madden, MSN, ANP-BC, AOCNP

Melanoma Program
NYU Langone Perlmutter Cancer Center
New York, NY

ProCE Banner Faculty
Steven Maron, MD

Assistant Attending Physician
Gastrointestinal Medical Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Topics

Cases and Challenges in the Optimal Treatment of Metastatic Colorectal Cancer

Cases and Challenges in the Optimal Treatment of Advanced Gastric Cancer

Cases and Challenges in the Optimal Treatment of Advanced TNBC

Additional Info


CME/CE Info

Program Overview
Created specifically for the clinical needs of oncology NPs, PAs, and nurses, national experts will give their clinical perspectives on the management of gastrointestinal and breast cancers and prepare you for the future of care in these evolving fields. Live streamed for your convenience – all from the comfort of your home or office.


Target Audience
NPs, PAs, and nurses who specialize in oncology


Learning Objectives:


Cases and Challenges in the Optimal Treatment of Metastatic Colorectal Cancer

  • Identify patient- and disease-related factors that can impact selection of therapy for mCRC
  • Formulate strategies for use of novel therapies in mCRC
  • Apply recommendations to manage AEs of novel therapies for mCRC 


Cases and Challenges in the Optimal Treatment of Advanced Gastric Cancer

  • Identify current recommendations for molecular testing in advanced gastric cancer
  • Compose treatment strategies for patients with gastric cancer based on molecular testing, guideline recommendations, clinical trial evidence, and patient and disease factors 
  • Use recommended approaches to manage AEs associated with novel therapies 


Cases and Challenges in the Optimal Treatment of Advanced TNB

  • Describe rationale for and appropriate use of newer therapies in current standards of care for early and advanced TNBC
  • Integrate evidence-based advances into care of patients with TNBC
  • Employ proven strategies to recognize and mitigate toxicities of newer therapies to support optimal outcomes 

Accreditation

 

Joint Accreditation Statement



In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

ANCC Credit Designation

 

Nursing contact hours: 4.50, which includes 4.50 hours of pharmacology credit.

 

AAPA Credit Designation



Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

IPCE Credit Designation

 

 

 

This activity was planned by and for the healthcare team, and learners will receive 4.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

Disclosure of Conflicts of Interest 
Partners for Advancing Clinical Education (PACE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE)

Supported by educational grants from Gilead Sciences, Inc., Merck Sharp & Dohme Corp, and Taiho Oncology, Inc.